Recurrent Endometrial Cancer Not Yet Recruiting Phase 1 / 2 Trials for Olaparib (DB09074)

Also known as: Endometrial cancer recurrent / Cancer of endometrium recurrent / Ca endometrium recurrent / Endometrial carcinoma recurrent / Carcinoma endometrial recurrent

DBCOND0054384 (Recurrent Endometrial Cancer)Not Yet Recruiting1 / 2 IdentifierTitlePurposeDrugs
NCT02755844Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer PatientsTreatment